West Pharmaceutical Services Inc (WST) Stock Price & Analysis
West Pharmaceutical Services Inc (WST) fell 0.81% to USD 339.97 as of September 8, 2026 at 02:52 UTC, according to Nexqual real-time market data.
WST last closed at USD 339.97; the session ranged USD 339.77–342.66 on volume of 337,806 shares. Market capitalization is —, with a 52-week range of USD 223.83–386 (NYQ). Source: Nexqual, September 8, 2026 at 02:52 UTC.
Key Statistics (as of September 8, 2026 at 02:52 UTC)
| Price | USD 339.97 |
|---|---|
| Change | ▼ 0.81% (down) |
| Previous Close | USD 339.97 |
| Open | USD 339.97 |
| Day Range | USD 339.77 – 342.66 |
| 52-Week Range | USD 223.83 – 386 |
| Volume | 337,806 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (WST)
Nexqual's technical model rates WST "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 02:52 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 39.82 (neutral) |
| vs SMA50 | Below (USD 350.12) |
| MACD | -1.81 (negative) |
From West Pharmaceutical Services Inc's Latest SEC 10-K Filing (filed 2026-02-17)
Key Strengths & Strategy (as disclosed to the SEC)
- In addition to our Proprietary Products product portfolio, we provide our customers with a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support.
- Our products include a variety of primary proprietary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services and integrated solutions.
- Proprietary Products Segment Our Proprietary Products reportable segment offers elastomers & primary containment, drug delivery devices, integrated systems, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers.
- This focus on quality includes a commitment to excellence in manufacturing, scientific and technical expertise and management, which enables us to partner with our customers in order to deliver safe, effective drug products to patients quickly and efficiently.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| STE | STERIS plc (Ireland) | USD 224.59 | ▼ 2.5% |
| MTD | Mettler-Toledo International, I | USD 1,345.26 | ▼ 1.64% |
| TFX | Teleflex Incorporated | USD 138.36 | ▼ 1.85% |
| ROP | Roper Technologies, Inc. | USD 407.28 | ▼ 2.05% |
| COO | The Cooper Companies, Inc. | USD 69.59 | ▼ 0.2% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 02:52 UTC. This page is informational and not investment advice.